1. Abdenur JE, Solans CV, Smith MM, Carman C, Pugliese MT, Lifshitz F (1994) Body composition and spontaneous growth hormone secretion in normal short stature children. J Clin Endocrinol Metab 78(2):277–282
2. Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt–Rasmussen U, Hernberg–Stahl E, Westberg B, Wilton P, Wüster C (1999) The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH–deficient adults. KIMS Study Group and the KIMS International Board. J Clin Endocrinol Metab 84(11):3929–3935
3. Bereket A, Turan S, Omar A, Berber M, Ozen A, Akbenlioglu C, Haklar G (2006) Serum IGF–I and IGFBP–3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty. Horm Res 65(2):96–105
4. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA (1997) Growth hormone (GH)–deficient men are more responsive to GH replacement therapy than GH–deficient women. J Clin Endocrinol Metab 82(2):550–555
5. Ciresi A, Radellini S, Guarnotta V, Mineo MG, Giordano C (2018) The metabolic outcomes of growth hormone treatment in children are gender–specific. Endocr Connect 7(7):879–887